Leqvio FDA Approval

Flexibility, support and optionality will ensure seamless customer experience and timely access to Leqvio® Flexibility of acquisition and administration Robust network of >1,100 AICS ✓ ~75% of target HCPs have an AIC within 25 miles ✓ AIC locator tool available to providers and patients Support with initial acquisition and reimbursement complexity Largest access and reimbursement field team in the industry ✓ Establishing buy-and-bill infrastructure ✓ Understanding coding and reimbursement ✓ Navigating PA and medical exception process Optionality to address heterogenous customer needs Dedicated case managers ✓ Benefit verification and coverage support ✓ Co-pay assistance ✓ Billing and coding support Dedicated social workers ✓ Patient care program ✓ Adherence support LeqvioⓇ access and reimbursement website1 AIC Alternative injection center HCP Healthcare Professional PA Prior Authorization 1. Leqvio-access.com 24 Leqvio® FDA Approval | December 23, 2021 | Novartis Investor Presentation U NOVARTIS | Reimagining Medicine

View entire presentation